Comparing the performance of six human papillomavirus tests in a screening population

Cuzick, J, Cadman, L, Mesher, D, Austin, J, Ashdown-Barr, L, Ho, L, Terry, G, Liddle, S, Wright, C, Lyons, D, Szarewski, A·2013·British Journal of Cancer
DOI 10.1038/bjc.2013.22

Cited by (211)

Items 101–200 of 211

  1. Infecção por HPV em mulheres atendidas pela Estratégia Saúde da Família
    Andréia Rodrigues Gonçalves Ayres, Gulnar Azevedo e Silva, Maria Teresa Bustamante-Teixeira, Kristiane de Castro Dias Duque, Maria Lúcia Salim Miranda Machado, Carmen Justina Gamarra, José Eduardo Levi · 2017 · Revista de Saúde Pública
  2. Molecular diagnostic testing of cytology specimens: current applications and future considerations
    Jane Gibson, Stephen A. Young, Bing Leng, Riyam T. Zreik, Arundhati Rao · 2014 · Journal of the American Society of Cytopathology
  3. Analytical and Clinical Sample Performance Characteristics of the Onclarity Assay for the Detection of Human Papillomavirus
    Stephen A. Young, Laurence M. Vaughan, Karen A. Yanson, Karen Eckert, Aojun Li, James Harris, Aaron C. Ermel, James A. Williams, Mohammad Al-Ghoul, Catherine L. Cammarata et al. · 2020 · Journal of Clinical Microbiology
  4. HPV types in cervical cancer tissue in South Africa
    Amir Hooshang Fallah Rad, Sveinung Wergeland Sørbye, Greta Dreyer, Siri Hovland, Bente Marie Falang, Melanie Louw, Finn Egil Skjeldestad · 2017 · Medicine
  5. Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
    Maria Persson, K. Miriam Elfström, Sven-Erik Olsson, Joakim Dillner, Sonia Andersson · 2015 · PLoS ONE
  6. HPV Genotype Specific and Age Stratified Immediate Prevalence of Cervical Precancers and Cancers in Women with NILM/hrHPV+: A Single Center Retrospective Study of 26,228 Cases
    Qin Liu, Xin Zhou, Xiaofei Zhang, Amanda Louise Strickland, Wenxin Zheng, Hao Chen, Feng Zhou · 2021 · Cancer Management and Research
  7. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology
    Philip E. Castle, Jennifer Reid, Janel Dockter, Damon Getman · 2015 · Journal of Clinical Virology
  8. Detection of HPV mRNA in Self-collected Vaginal Samples Among Women at 69-70 Years of Age
    Avalon Ernstson, Katrin Christine Asciutto, JOHAN STURESSON, Jonas Norén, Ola Forslund, Christer Borgfeldt · 2018 · Anticancer Research
  9. Referral population studies underestimate differences between human papillomavirus assays in primary cervical screening
    Matejka Rebolj, Sisse Helle Njor, Elsebeth Lynge, Sarah Preisler, Ditte Møller Ejegod, Carsten Rygaard, Jesper Hansen Bonde · 2017 · Cytopathology
  10. The Potential Clinical and Economic Value of a Human Papillomavirus Primary Screening Test That Additionally Identifies Genotypes 31, 45, 51, and 52 Individually
    Lindsey Asti, Colin D.J. Hopley, Cameron Avelis, Sarah M. Bartsch, Leslie E. Mueller, Molly Domino, Sarah N. Cox, Jeffrey Campbell Andrews, Samuel L. Randall, Owen J. Stokes-Cawley et al. · 2020 · Sexually Transmitted Diseases
  11. Enhancing Cervical Cancer Prevention in South African Women: Primary HPV mRNA Screening with Different Genotype Combinations
    Sveinung Wergeland Sørbye, Bente Marie Falang, Matthys Hendrik Botha, Leon Cornelius Snyman, Frederick Haynes Van der Merwe, Cathy Visser, Karin Louise Richter, Greta Dreyer · 2023 · Cancers
  12. Aptima HPV messenger RNA testing and histopathologic follow‐up in women with HSIL cytology: A study emphasizing additional review of HPV‐negative cases
    Aofei Li, Juan Li, R. Marshall Austin, Tiannan Wang, Dayne Ashman, Huina Zhang, Jonee Matsko, Chengquan Zhao · 2021 · Cancer Cytopathology
  13. Assessment of Cervical Cancer Molecular-Based Screening Tools; HPV-DNA Detection versus E6/E7 mRNA Testing; First Report of a Prospective Cohort Study among Iranian Women
    Azamsadat Mousavi, Ali Pouryasin, Fariba Yarandi, Leila Pirzadeh, Abbas Alipour, Shakiba Khodadad, Mohammad Pouryasin · 2020 · Iranian Journal of Public Health
  14. Human papillomavirus detection with genotyping by the cobas and Aptima assays: Significant differences in HPV 16 detection?
    Joseph A. Chorny, Teresa C. Frye, Beth L. Fisher, Carol Remmers · 2018 · Diagnostic Cytopathology
  15. Introducing human papillomavirus (HPV) primary testing in the age of HPV vaccination: projected impact on colposcopy services in Wales
    Francesca Pesola, Matejka Rebolj, Simon C. Leeson, Louise Dunk, L Pickford, Ardiana Gjini, Peter David Sasieni · 2020 · BJOG An International Journal of Obstetrics & Gynaecology
  16. AACC Guidance Document on Cervical Cancer Detection: Screening, Surveillance, and Diagnosis
    Yusheng Zhu, Sarah Feldman, Shuk On Annie Leung, Michael H. Creer, Joshua I. Warrick, Nicole Williams, Stephen Mastorides · 2023 · The Journal of Applied Laboratory Medicine
  17. Clinical performance of Onclarity HPV assay and Cobas HPV test in detection of cervical precancer and cancer in Chinese women
    Tingyuan Li, Zeni Wu, Mingyue Jiang, Yuqian Zhao, Lulu Yu, Yu Qin, Bin Liu, Jianfeng Cui, Li Li, Qinjing Pan et al. · 2020 · Gynecologic Oncology
  18. Health economic evaluation of an mRNA high-risk human papillomavirus (HR-HPV) assay versus a DNA HR-HPV assay for the proposed French cervical screening programme
    Caroline A. Dombrowski, Georgie Weston, Philippe Descamps, Jacques Izopet, Elisabeth Jane Adams, Elisabeth Jane Adams · 2022 · Medicine
  19. Human Papillomavirus (HPV) Testing for Secondary Prevention of Cervical Cancer
    Partha Sarathi Basu, Smita Joshi, Rengaswamy Sankaranarayanan · 2015 · Current Obstetrics and Gynecology Reports
  20. Comparison of the digene hybrid capture 2 and Roche cobas 4800 HPV tests for detection of CIN2+ in a referral population in Japan
    Toshiyuki Sasagawa, Toshiyuki Maehama, Yasuhiro Osaka, Jinichi Sakamoto, Takeo Shibata, Satoko Fujita, Masahiro Takakura, Hiroaki Takagi · 2018 · Journal of Medical Virology
  21. Molecular Markers for the Diagnosis of High-Risk Human Papillomavirus Infection and Triage of Human Papillomavirus-Positive Women
    Kirvis Torres-Poveda, Patricia Piña‐Sánchez, Verónica Vallejo‐Ruiz, Marcela Lizano, Aurelio Cruz-Valdéz, Paula Juarez-Sánchez, Jaime de la Garza-Salazar, Joaquín Manzo-Merino · 2020 · Revista de investigaci�n Cl�nica
  22. Paradigm shift needed for cervical cancer: HPV infection is the real epidemic
    Karin Louise Richter, Greta Dreyer · 2013 · South African Medical Journal
  23. Enhancing Cervical Cancer Screening with 7-Type HPV mRNA E6/E7 Testing on Self-Collected Samples: Multicentric Insights from Mexico
    Carlos Eduardo Aranda-Flores, Bente Marie Falang, Laura Gómez-Laguna, Guillermo Gómez Gutiérrez, Jorge M Ortiz León, Miguel Uribe, Omar Cruz, Sveinung Wergeland Sørbye · 2024 · Cancers
  24. Comparative cost analysis of cervical cancer screening programme based on molecular detection of HPV in Spain
    Raquel Ibáñez, María Mareque, Rosario Granados, Daniel Andı́a, Marcial García‐Rojo, Jose C Quílez, Itziar Oyagüez · 2021 · BMC Women s Health
  25. Utility of Extended HPV Genotyping as Primary Cervical Screen in an Unscreened Population With High HIV Co-Infection Rate
    Matthys Hendrik Botha, Frederick Haynes Van der Merwe, Leon Cornelius Snyman, Gerrit Jan Dreyer, Cathy Visser, Greta Dreyer · 2023 · Journal of Lower Genital Tract Disease
  26. Hybrid Capture 2 and cobas human papillomavirus assays perform similarly on SurePath samples from women with abnormalities
    Delfina Fornari, Matejka Rebolj, B. Bjerregård, Marianne Lidang, Ib Jarle Christensen, Estrid Vilma Solyom Høgdall, Jesper Hansen Bonde · 2016 · Cytopathology
  27. HPV genotyping and E6/E7 transcript assays for cervical lesion detection in an Asian screening population—Cobas and Aptima HPV tests
    Oscar Gee‐Wan Wong, Obe K. L. Tsun, Eva Y. Tsui, Joanne N. K. Chow, Philip P.C. Ip, Any Cheung · 2018 · Journal of Clinical Virology
  28. Evaluation of the Onclarity HPV assay on the high-throughput COR system
    Stephanie N. Taylor, Karen Eckert, Agnieszka A. Rucki, Michael VanSickler, James A. Price, Erin C. Gutierrez, Mike Lizzi, Catherine L. Cammarata, Benjamin von Bredow, David M. Wolfe et al. · 2021 · Expert Review of Molecular Diagnostics
  29. Preinvasive Disease of the Cervix
    Leslie Stewart Massad · 2017 · Elsevier eBooks
  30. Application of one-dimensional hierarchical network assisted screening for cervical cancer based on Raman spectroscopy combined with attention mechanism
    Ziwei Yan, Chenjie Chang, Zhenping Kang, Chen Chen, Xiaoyi Lv, Cheng Chen · 2024 · Photodiagnosis and Photodynamic Therapy
  31. Comparative evaluation of Anyplex II HPV28 and Allplex HPV28 molecular assays for human papillomavirus detection and genotyping in anogenital cancer screening
    Klaudia Naegele, Lukas Bubendorf, Hans Hellmuth Hirsch, Karoline Leuzinger · 2024 · Journal of Medical Virology
  32. High-risk human papillomavirus (HPV) detection in formalin-fixed paraffin-embedded cervical tissues: performances of Aptima HPV assay and Beckton Dickinson (BD) Onclarity assay
    Gözde Kır, Humeyra Gunel, Zeynep Cagla Tarcan, Wilson Glenn McCluggage · 2021 · Journal of Clinical Pathology
  33. Correlation of immediate prevalence of cervical precancers and cancers with HPV genotype and age in women with ASC-US/hrHPV+: a retrospective analysis of 2292 cases
    Qin Liu, Tao Zhang, Liqing Chen, Xin Zhou, Xiaofei Zhang, Wenxin Zheng, Shuang Niu, Feng Zhou · 2023 · Journal of Clinical Pathology
  34. Risk of Intraepithelial Neoplasia Grade 3 or Worse (CIN3+) among Women Examined by a 5-Type HPV mRNA Test during 2003 and 2004, Followed through 2015
    Amir Rad, Sveinung Wergeland Sørbye, Sweta Tiwari, Maja‐Lisa Løchen, Finn Egil Skjeldestad · 2023 · Cancers
  35. Prevalence of cervical precancers or cancers in women with ASC-H/HSIL cytology according to Aptima HPV (AHPV) assay-detected HPV genotypes and age
    Qin Liu, Liqing Chen, Minghua Yu, Xin Zhou, Xiaofei Zhang, Wenxin Zheng, Shuang Niu, Feng Zhou · 2023 · Journal of Cancer
  36. RNA extended interventional nucleic acid longitudinal study: Clinical performance of Aptima messenger RNA HPV testing in cervical cancer screening with a 9‐year follow‐up
    Rosario Granados, Joanny A. Duarte, David Ricardo Luján-Rodríguez, Ana Gutiérrez-Pecharromán, Isabel Solís, Lourdes Molpeceres, Paloma Bajo, Elsa Palencia, Nuria Martín · 2024 · Cancer Cytopathology
  37. Limitations on the Detection Rate of High-Risk HPV by Hybrid Capture 2 Methodology in High Grade Intraepithelial (HSIL) or Atypical Squamous Cells-Cannot Exclude HSIL (ASC-H) Cytological Lesions with Proved CIN2+
    Jean‐Christophe Noël, Philippe Simon · 2015 · Analytical Cellular Pathology
  38. Development of a Multiplex PCR Test with Automated Genotyping Targeting E7 for Detection of Six High-Risk Human Papillomaviruses
    Eliana Ferreira Paes, Ângela Maria de Assis, Cirbia Silva Campos Teixeira, Francisco Hideo Aoki, Júlio César Teixeira · 2015 · PLoS ONE
  39. Moderne Diagnostik sexuell übertragbarer Infektionen
    Norbert Hermann Brockmeyer, Thomas Meyer · 2015 · Der Hautarzt
  40. A study of hormonal effects in cervical smear samples using Raman spectroscopy
    Damien Traynor, Padraig Kearney, Inês Ramos, Cara M. Martin, John J. O’Leary, Fiona M. Lyng · 2017 · Journal of Biophotonics
  41. Concordance of Anyplex™ II HPV HR assays with reference HPV assays in cervical cancer screening: Systematic review
    Biazin, Habtamu · 2022 · Journal of Virological Methods
  42. Molecular Screening for Cervical Cancer
    Toni Ricardo Martins, José Eduardo Levi · 2025 · Genes
  43. Correlation of immediate prevalence of cervical squamous cell precancers and cancers with HPV genotype and age in women with LSIL cytology: A retrospective analysis of 1617 cases
    Liqing Chen, Kaibo Zhu, Hao Chen, Qin Liu, Xiao-Fei Zhang, Xin Zhou, Jun Zhang, Shuang Niu, Feng Zhou · 2023 · Diagnostic Cytopathology
  44. The Distribution of HR‐HPV E6/E7 DNA and mRNA by Histological Grade and the Clinical Performance for Detection of Cervical Cancer and Precancer
    Rong Pi, Tingyuan Li, Hua Zhang, Hang Zhou, Yuan Yang, Yu Dai, Zeni Wu, Mingyue Jiang, Wen Chen, Lan Zhu · 2024 · Journal of Medical Virology
  45. Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis
    Daniel Figueiredo, Inês Ribeiro, Ana Penedones, Diogo Mendes, Carlos Alves, Francisco Batel Marques, Daniel Pereira da Silva · 2023 · BMC Women s Health
  46. Comparison of the clinical performance of OmniPlex-HPV and GeneFinder HPV for the detection and genotyping of human papillomaviruses in cervical specimens
    Geehay Hong, Yun Guk Park, Han Wool Jin, Sam Kyu Choi, Hyun Young Chi, Woo Jae Cho, Joo Hee Lee, Sol Han, Sun Pyo Hong · 2018 · Journal of Medical Microbiology
  47. Broad-Range Papillomavirus Transcriptome as a Biomarker of Papillomavirus-Associated Cervical High-Grade Cytology
    Philippe Pérot, Anne Biton, J. Marchetta, Anne-Gaëlle Pourcelot, André Nazac, Henri Marret, Thomas Hébert, Delphine Chrétien, Marie-Christine Demazoin, Michaël Falguières et al. · 2019 · Journal of Molecular Diagnostics
  48. Performance analysis of high‐throughput HPV testing on three automated workflows
    Anne J. M. Loonen, Cornelis J. J. Huijsmans, Willemina R.R. Geurts-Giele, Cindy Leeijen, Johannes Cornelis van der Linden, Adriaan J. C. van den Brule · 2020 · Apmis
  49. Consistency evaluation of Liferiver, Yaneng, Darui, and the Cobas 4800 test for high‐risk human papillomavirus screening
    Mengmeng Wang, Xiang Ji, Xiaowen Dou, Huamei Tang, Lijuan Kan, Wei Wu, Dayang Chen, Zengyan Zong, Dan Xiong, Xiuming Zhang · 2020 · Journal of Clinical Laboratory Analysis
  50. Molecular testing for human papillomaviruses
    Katie M. Bennett · 2023 · Elsevier eBooks
  51. Concordance between the BD Onclarity and Roche cobas assays for detection of HPV DNA in a Chinese population
    Yakun Wang, Tingyuan Li, Jian Yin, Yin Liu, Zhifang Li, Yujing Liu, Tingting Chen, Simiao Chen, Yu Dai, Jianfeng Cui et al. · 2022 · Journal of Medical Virology
  52. Wavelet scattering transform and entropy features in fluorescence spectral signal analysis for cervical cancer diagnosis
    Bhaswati Singha Deo, Sidharthenee Nayak, Mayukha Pal, Prasanta K. Panigrahi, Asima Pradhan · 2024 · Biomedical Physics & Engineering Express
  53. Empirical mode decomposition and Hessian LLE in Fluorescence spectral signal analysis for Cervical cancer detection
    Bhaswati Singha Deo, Sidharthenee Nayak, Mayukha Pal, Prasanta Kumar Panigrahi, Asima Pradhan · 2024 · Biomedical Signal Processing and Control
  54. High-risk HPV detection and genotyping by APTIMA HPV using cervical samples
    Michael T. Pyne, Camille L. A. Hamula, Keith D. Tardif, Christian L Law, Robert Schlaberg · 2015 · Journal of Virological Methods
  55. Microbiological diagnosis of human papilloma virus infection
    María Luisa Mateos‐Lindemann, Sonia Pérez‐Castro, Manuel Rodríguez‐Iglesias, María Teresa Pérez‐Gracia · 2017 · Enfermedades infecciosas y microbiologia clinica (English ed )
  56. Accuracy of combined molecular and morphology-based triage for HPV-positive women in routine cervical cancer screening services from Colombia
    Raúl Murillo, Óscar Gamboa, Gustavo A. Hernandez-Suarez, Mauricio González, Peter Alfonso Olejua, Mónica Molano, Carolina Wiesner · 2021 · Preventive Medicine
  57. HPV E1 qPCR, a Low-Cost Alternative Assay to Roche Diagnostic Linear Array is Effective in Identifying Women at Risk for Developing Cervical Cancer
    Chandrika J Piyathilake, Suguna Badiga, Janice L Simons, Walter C Bell, Pauline E Jolly · 2022 · International Journal of Women s Health
  58. Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States
    Cosette Marie Wheeler, Norah E Torrez-Martinez, Edith Torres-Chavolla, Valentin Parvu, Jeffrey Campbell Andrews, Ruofei Du, Michael Robertson, Nancy E. Joste, Jack M. Cuzick, Nancy E. Joste et al. · 2023 · American Journal of Obstetrics and Gynecology
  59. Comparative analysis of cervical cytology and human papillomavirus genotyping by three different methods in a routine diagnostic setting
    Elizaveta Y. Padalko, Catherine Ali-Risasi, Stéphanie Mesmaekers, Inge Ryckaert, Lieve Van Renterghem, Kathleen Lambein, Mieke Bamelis, Anja De Mey, Yolande Sturtewagen, Hilde Vastenavond et al. · 2014 · European Journal of Cancer Prevention
  60. Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens
    Thomas Iftner, Lisa E. Wang, Angelika Iftner, Barbara Holz, Juliane Haedicke, Nathalie Iftner, Reinhard von Wasielewski, Peter Martus, Gerd Boehmer · 2016 · BMC Infectious Diseases
  61. The potential of RNA as a target for national screening of pre-cancer
    Frank Karlsen, Margaret Muturi, Cosmas Muyabwa, Lars Eric Roseng, Serge Bigabwa, Byamungu Chihongola, Lucy Wangari Muchiri · 2018 · Journal of Public Health in Africa
  62. Application of the Cobas 4800 System for the Detection of High‐Risk Human Papillomavirus in 5650 Asymptomatic Women
    Shanyun Wang, Xijun He, Fansu Meng, Qianyi Pan, Lin Zhang, Jianfeng Zeng · 2020 · BioMed Research International
  63. Assessing the detection of human papillomavirus late mRNA in liquid base cytology samples for risk stratification of cervical disease
    George Chambers, David W. M. Millan, Kate S. Cuschieri, Heather Cubie, Sheila V. Graham · 2013 · Journal of Medical Virology
  64. Frequency of sexually transmitted diseases and main methodological implications
    Zaleida Napoli, Patrizia Lencioni, Margherita Niccolai, Riccardo Lari, Loria Bianchi · 2013 · Microbiologia medica
  65. Human papillomavirus mRNA and DNA testing in women with atypical squamous cells of undetermined significance: A prospective cohort study
    Louise Thirstrup Thomsen, Christian Dehlendorff, Jette Junge, Marianne Waldstrøm, Doris Schledermann, Kirsten Frederiksen, Susanne K. Kjær · 2016 · International Journal of Cancer
  66. Neue Biomarker in der Prävention des Zervixkarzinoms
    Matthias Jentschke, Philipp Soergel, Peter Hillemanns · 2013 · Der Gynäkologe
  67. Cervical Human Papillomavirus Testing
    Carol N. Rizkalla, Eric C. Huang · 2024 · Surgical pathology clinics
  68. Human papillomavirus testing in patients with invasive cervical carcinoma: An institutional experience
    Nhu Thuy Can, Vera Tešić, Tatjana Antic · 2014 · Journal of the American Society of Cytopathology
  69. Human papillomavirus (HPV) DNA and mRNA primary cervical cancer screening: Evaluation and triaging options for HPV-positive women
    Suleeporn Sangrajrang, Piyawat Laowahutanont, Metee Wongsena, Richard Muwonge, Weerawut Imsamran, Pattama Ploysawang, Partha Sarathi Basu · 2019 · Journal of Medical Screening
  70. Cervical Cancer Screening by Association of Liquid-Based Cytology with Real-Time PCR for High-Risk Human Papillomavirus in Women Assisted in a Clinical Analysis Laboratory
    Renan Chaves de Lima, Isabella Pinheiro Costa do Amaral, Fernando Antonio Alves da Silveira, Letícia Cristina Dalzy Castro, Igor Brasil Costa, Luiz Carlos Santana da Silva · 2021 · SN Comprehensive Clinical Medicine
  71. Cervical cytology and HPV in cervical cancer screening
    Pooja Bakshi, Poojan Agarwal, Gunjan Mangla · 2023 · Current Medicine Research and Practice
  72. Biomarkers in the Screening and Management of Cervical Cancer
    Pallavi Punhani, Charanjeet Ahluwalia · 2024 · Journal of Colposcopy and Lower Genital Tract Pathology
  73. Empirical Mode Decomposition and Grassmann Manifold‐Based Cervical Cancer Detection
    Sidharthenee Nayak, Bhaswati Singha Deo, Mayukha Pal, Prasanta Kumar Panigrahi, Asima Pradhan · 2025 · Journal of Biophotonics
  74. Comparison of different mRNA testing technologies with HPV DNA testing for predicting ASCUS triage and post-cone excision outcomes: a systematic review and meta-analysis
    Chao Zhao, Mingzhu Li, Rui Chen, Yun Zhao, Jingran Li, Wei Zhao, X. Li, J J Zhang, Shaolan Yu, Lihui Wei · 2026 · Systematic Reviews
  75. An ensemble feature ranking framework for the assessment of the efficacy of cervical cancer detection tests and human papillomavirus genotypes in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma
    Panagiotis Bountris, Charalampos Tsirmpas, Maria Haritou, Abraham Pouliakis, Ioannis Kouris, Petros Karakitsos, Dimitris Koutsouris · 2015 · IEEE International Conference on Bioinformatics and Bioengineering (BIBE)
  76. Molecular Testing for Human Papillomaviruses
    Katie M. Bennett · 2016 · Elsevier eBooks
  77. Comparison of Siriraj liquid‐based solution and standard transport media for the detection of high‐risk human papillomavirus in cervical specimens
    Atthapon Jaishuen, Nida Jareemit, Somsak Laiwejpithaya, Boonlert Viriyapak, Mongkol Benjapibal, Navin Horthongkham · 2018 · Journal of Medical Virology
  78. The routine use of LCD-Array hybridisation technique for HPV subtyping in the diagnosis of penile carcinoma compared to other methods
    Ria Winkelmann, Katrin Bankov, Jens von der Grün, Jindrich Jr. Cinatl, Peter Johannes Wild, Stefan Vallo, Melanie C Demes · 2022 · BMC Urology
  79. Human Papillomaviruses
    Christine C. Ginocchio, Patti E. Gravitt, Jennifer S. Smith · 2015 · ASM Press eBooks
  80. Molecular detection of hrHPV-induced high-grade squamous intraepithelial lesions of the cervix through a targeted RNA next generation sequencing assay
    Julia Faillace Thiesen, Elise Jacquemet, Pascal Campagne, Denis Chatelain, Étienne Brochot, Yves-Édouard Herpe, Nolwenn Marie Dheilly, Fabrice Bouilloux, Bénédicte Rognon, Alexandre Douablin et al. · 2025 · Molecular Medicine
  81. Molecular diagnostics of infectious disease: Detection and characterization of microbial agents in cytology samples
    Carla R. Caruso, Zhongbo Yang · 2022 · Diagnostic Cytopathology
  82. New diagnostic and prognostic methods to improve the effectiveness of cervical cancer screening
    Maria Persson · 2014 · Figshare
  83. Workflow and Maintenance Characteristics of Five Automated Laboratory Instruments for Molecular Assays That Detect Sexually Transmitted Infections
    Sam Ratnam, Dan Jang, Jodi Gilchrist, Marek Smieja, André Poirier, Todd F. Hatchette, Jean-Frederic Flandin, Max Chernesky · 2014
  84. Cervical Cancer Screening at a Crossroads: Learnings from the Past Driving Change for the Future
    Laurence M. Vaughan, Brian Faherty, Erin C. Gutierrez, James M. Harris, William A. Nussbaumer, Ryan J. Schwab · 2016 · InTech eBooks
  85. HPV Detection Methods
    Aris Spathis, Christine Kottaridi, Abraham Pouliakis, Stavros K. Archondakis, Petros Karakitsos · 2015 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  86. [Treatment of purulent-inflammatory complications of the soft tissues wounds in elderly and senile patients].
    V S Shevchenko, V D Malyk, E O Fedoryna · 2001 · PubMed
  87. Primary Screening by Human Papillomavirus Testing: Development, Implementation, and Perspectives
    Chris J.L.M. Meijer, Jack M. Cuzick, Wieke W. Kremer, Daniëlle A.M. Heideman, Guglielmo Ronco · 2019 · Elsevier eBooks
  88. Knowledge and Awareness about Cervical Cancer amongst Physiotherapist of Ahmedabad- an Observational Study
    Margi Pandya, Sadhana Mukhi · 2020 · International Journal of Health Sciences and Research
  89. Reply to: Comments on cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta‐analysis
    Talía Malagón, Karena D. Volesky, Eduardo Luis Franco · 2021 · International Journal of Cancer
  90. HPV Detection Methods
    Aris Spathis, Christine Kottaridi, Abraham Pouliakis, Stavros K. Archondakis, Petros Karakitsos · 2016 · IGI Global eBooks
  91. Desenvolvimento de um teste biomolecular para detecção de HPV em amostras cervicouterinas
    Eliana Ferreira Paes · 2015
  92. HPV and Other Molecular Testing in Gynecologic Cytology
    2018 · Elsevier eBooks
  93. Modern approaches to cervical cancer screening (a review)
    Mykhailo Pavliuchenko, Yu. Ya. Krut, V. H. Sіusіuka, O.V. Deinichenko · 2023 · Pathologia
  94. A study on Fourier Bessel Series Expansion and Hessian LLE for cervical cancer detection
    Bhaswati Singha Deo, Shivam Shukla, Sweta Singh, Ashok Kumar Padhi, Neena Gupta, S.N. Prasad, Mayukha Pal, Prasanta Kumar Panigrahi, Asima Pradhan · 2024 · Optics Communications
  95. Detection of cervical precancerous lesions and cancer by small-scale RT-qPCR analysis of oppositely deregulated mRNAs pairs in cytological smears
    Anastasia A. Artyukh, Mikhail Ivanov, Sergei Evgenievich Titov, Victoria V. Dzyubenko, Sergey E. Krasilnikov, Anastasia O. Shumeikina, Nikita A. Afanasev, Anastasia V. Malek, Sergei A. Glushkov, Eduard Feliksovich Agletdinov · 2025 · Frontiers in Oncology
  96. Hepatocyte nuclear factor 4 alpha immunocytochemistry: A useful marker for detecting endocervical glandular lesions in alcohol‐fixed smears
    Yuri Noda, Kaori Sando, Masato Kita, Koji Tsuta · 2025 · Cancer Cytopathology
  97. Benign Proliferative Reactions, Intraepithelial Neoplasia, and Invasive Cancer of the Uterine Cervix
    Michael R. Henry, Sarah E. Kerr · 2015 · Elsevier eBooks
  98. Prognostic Significance of Histopathological and Hematological Markers in Gastrointestinal Stromal Tumors
    Adem Şentürk, Emre Gönüllü, Alp Ömer Cantürk, Ahmet Tarık Harmantepe, Recayi Çapoğlu, Fuldem Mutlu · 2025 · Acta Medica Nicomedia
  99. Current insights on human Papillomavirus-independent cervical cancers: a systematic review
    Ana Beatriz Camillo Santos, Marcos Elias da Silva Almeida, Lucimara Rodrigues Carobeli, Lyvia Eloiza de Freitas Meirelles, Maria Vitória Felipe de Souza, Gabriela de Castro Prado, Edilson Damke, Valeria Raissa Oliveira da Silva, Jorge Juarez Vieira Teixeira, Marcia Edilaine Lopes Consolaro · 2025 · Brazilian Journal of Pharmaceutical Sciences
  100. Additional file 3 of The routine use of LCD-Array hybridisation technique for HPV subtyping in the diagnosis of penile carcinoma compared to other methods
    Ria Winkelmann, Katrin Bankov, Jens von der Grün, Cinatl, Jindrich, Peter Johannes Wild, Stefan Vallo, Melanie C Demes · 2022 · Figshare